PRELUDE CAPITAL MANAGEMENT, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 68 filers reported holding ANI PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$9,000
-92.7%
126
-93.2%
0.00%
-92.3%
Q3 2016$123,000
+39.8%
1,858
+18.0%
0.01%
+8.3%
Q2 2016$88,000
+63.0%
1,574
+31.2%
0.01%
+50.0%
Q4 2015$54,000
-20.6%
1,200
+9.1%
0.01%
-20.0%
Q2 2015$68,000
+54.5%
1,100
+57.1%
0.01%
+66.7%
Q1 2015$44,000
-44.3%
700
-50.0%
0.01%
-50.0%
Q4 2014$79,000
-63.8%
1,400
-81.8%
0.01%
-61.3%
Q3 2014$218,000
+373.9%
7,700
+470.8%
0.03%
+416.7%
Q2 2014$46,000
-31.3%
1,349
-37.2%
0.01%
-33.3%
Q1 2014$67,0002,1490.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 326,778$20,152,0002.95%
Hawk Ridge Capital Management 188,761$11,641,0001.89%
Global Alpha Capital Management Ltd. 169,746$10,468,0001.55%
Mesirow Financial Investment Management, Inc. 5,723$353,0001.49%
1492 Capital Management LLC 25,093$1,547,0001.37%
THB ASSET MANAGEMENT 91,018$5,613,0001.04%
Regent Investment Management LLC 41,329$2,549,0000.78%
Phocas Financial Corp. 101,567$6,263,0000.75%
INVESTMENT COUNSELORS OF MARYLAND LLC 284,334$17,535,0000.75%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$2,189,0000.70%
View complete list of ANI PHARMACEUTICALS INC shareholders